
3 Packaging Products Maker, Phosphate Fertilisers Maker and Hospitals Chain Stocks With a Strong Future Roadmap: TCPL Packaging, Paradeep Phosphates and Max Healthcare Institute
TCPL Packaging, Paradeep Phosphates and Max Healthcare Institute: ROE of 13.4% to 14.7% and FY22 to FY26 revenue CAGR of 14.0% to 29.1%. Prices as of 13 Nov 2026.
Updated: 16 Nov 2026 • 2:23 pm
Posted by:

Quick Answer
The three packaging, fertiliser and hospital stocks to watch are TCPL Packaging, Paradeep Phosphates and Max Healthcare Institute. Their return on equity ranges from 13.4% to 14.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.0% to 29.1%. Paradeep Phosphates leads on both return on equity at 14.7% and revenue growth at 29.1% a year. Prices are based on the 13 November 2026 close, and this article is educational, not investment advice.
Packaging, fertiliser and hospital stocks give investors a way to track businesses that sit close to everyday demand in India. TCPL Packaging, Paradeep Phosphates and Max Healthcare Institute cover a packaging products maker, a phosphate fertilisers maker and a hospitals chain.
This list covers three packaging, fertiliser and hospital stocks with complete current figures: TCPL Packaging, Paradeep Phosphates and Max Healthcare Institute. Every figure comes from the latest reported financials and the 13 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Packaging, Fertiliser and Hospital Stocks?
Packaging, fertiliser and hospital stocks are listed companies that make folding cartons and packaging for consumer brands, make phosphate fertilisers for farmers, and run multi speciality hospitals. Their earnings depend on packaging orders, farm demand and patient volumes.
Packaging, Fertiliser and Hospital Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| TCPL Packaging | 4,481.5 | 3,524 | 30.5 | 21.7 | 13.6 | 0.88 |
| Paradeep Phosphates | 140.41 | 15,007 | 14.0 | 21.2 | 14.7 | 1.02 |
| Max Healthcare Institute | 947.1 | 80,717 | 55.4 | 59.6 | 13.4 | 0.32 |
On valuation, Paradeep Phosphates and Max Healthcare Institute trade at a P/E below the industry P/E, while TCPL Packaging trades above it, which reflects the growth the market already expects. Readers comparing packaging, fertiliser and hospital stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in packaging, fertiliser and hospital stocks can use the coming numbers to test whether growth is holding.
Why Do Packaging, Fertiliser and Hospital Stocks Have a Strong Roadmap in India?
Packaging, fertiliser and hospital stocks have a strong roadmap in India because rising demand for printed packaging, steady farm activity and rising need for quality hospital care keep widening the market for these companies.
- Packaging. Brands need quality retail packs.
- Fertilisers. Farmers need crop nutrients.
- Hospitals. Families seek quality specialist care.
Why TCPL Packaging Features Among These Packaging, Fertiliser and Hospital Stocks
Among the packaging, fertiliser and hospital stocks on this list, TCPL Packaging makes printed folding cartons, laminates and labels for consumer goods, personal care and pharmaceutical customers. It is a supplier to many leading brands in India and overseas.
The company has a return on equity of 13.6%, a debt to equity ratio of 0.88 and a market capitalisation of Rs 3,524 crore. The stock trades at a P/E of 30.5, above the industry P/E of 21.7.
Revenue rose from Rs 1,089 crore in FY22 to Rs 1,836 crore in FY26, a compound annual growth rate of 14.0%. Net profit grew from Rs 46.9 crore in FY22 to Rs 97.8 crore in FY26, which works out to a compound annual growth rate of 20.2%. In the June 2026 quarter, revenue grew 15.9% year on year to Rs 495 crore, while net profit rose 79.3% to Rs 40.0 crore.
Roadmap: The company is investing in new plants and printing technology to serve brand owners who want quality packaging at scale. Rising packaged consumption supports steady volume growth.
What to watch: Follow capacity additions and the growth of export and pharmaceutical packaging.
Why Paradeep Phosphates Features Among These Packaging, Fertiliser and Hospital Stocks
Among the carton maker, phosphate maker and healthcare chain shares on this list, Paradeep Phosphates makes phosphatic fertilisers such as DAP and NPK grades from its plant in Odisha, serving farmers across eastern and central India.
Revenue rose from Rs 7,898 crore in FY22 to Rs 21,973 crore in FY26, a compound annual growth rate of 29.1%. Net profit grew from Rs 398 crore in FY22 to Rs 996 crore in FY26, which works out to a compound annual growth rate of 25.8%.
In the June 2026 quarter, revenue grew 35.4% year on year to Rs 6,146 crore, while net profit rose 23.9% to Rs 393 crore. The company has a return on equity of 14.7%, a debt to equity ratio of 1.02 and a market capitalisation of Rs 15,007 crore. The stock trades at a P/E of 14.0, below the industry P/E of 21.2.
Roadmap: The company has expanded capacity and is working to increase volumes of complex fertilisers across its network. Its coastal location supports imports of raw material, and expansion plans support future volumes.
What to watch: Watch raw material prices, subsidy policy and the volume of new capacity coming on stream.
Why Max Healthcare Institute Features Among These Packaging, Fertiliser and Hospital Stocks
Among the three companies on this list, Max Healthcare Institute runs a large network of multi-specialty hospitals concentrated in Delhi NCR, Punjab, Uttarakhand and Maharashtra, with a strong presence in oncology, cardiac sciences, neurosciences and orthopaedics.
In the June 2026 quarter, revenue grew 16.6% year on year to Rs 2,407 crore, while net profit rose 4.9% to Rs 323 crore. Revenue rose from Rs 4,059 crore in FY22 to Rs 8,536 crore in FY26, a compound annual growth rate of 20.4%.
Net profit grew from Rs 605 crore in FY22 to Rs 1,442 crore in FY26, which works out to a compound annual growth rate of 24.3%. The company has a return on equity of 13.4%, a debt to equity ratio of 0.32 and a market capitalisation of Rs 80,717 crore. The stock trades at a P/E of 55.4, below the industry P/E of 59.6.
Roadmap: The roadmap rests on adding beds through brownfield expansion at existing campuses and through new hospitals in cities where the group already has referral strength. Higher bed occupancy and a richer case mix lift revenue per occupied bed, which is the number hospital analysts follow most closely.
What to watch: Track how quickly new beds reach stable occupancy and whether average revenue per occupied bed keeps rising.
TCPL Packaging vs Paradeep Phosphates vs Max Healthcare Institute on Key Financials
The table below sets the three packaging, fertiliser and hospital stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| TCPL Packaging | 1,089 | 1,836 | 14.0% | 97.8 | 5.3% |
| Paradeep Phosphates | 7,898 | 21,973 | 29.1% | 996 | 4.5% |
| Max Healthcare Institute | 4,059 | 8,536 | 20.4% | 1,442 | 16.9% |
Paradeep Phosphates posts the highest return on equity in this group at 14.7%. Paradeep Phosphates combines the largest FY26 revenue at Rs 21,973 crore with the fastest revenue growth, a 29.1% compound annual rate. A useful habit with packaging, fertiliser and hospital stocks is to check each new quarterly result against the capacity plans the company described earlier.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| TCPL Packaging | 427 | 495 | 15.9% |
| Paradeep Phosphates | 4,538 | 6,146 | 35.4% |
| Max Healthcare Institute | 2,064 | 2,407 | 16.6% |
Key Risks to Check Before Investing in Packaging, Fertiliser and Hospital Stocks
Every theme carries risks that deserve a check before any decision. For these packaging, fertiliser and hospital stocks, the main points are: Long-term carton maker, phosphate maker and healthcare chain shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Raw material costs. Ingredient and packaging prices can move margins.
- Season and monsoon. Crop protection sales follow rain and pest cycles.
- Capacity ramp up. New hospitals take time to fill beds and reach full returns.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter packaging, fertiliser and hospital stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Packaging, Fertiliser and Hospital Stocks
Packaging, fertiliser and hospital stocks work best when investors track growth, valuation and return on equity side by side. TCPL Packaging, Paradeep Phosphates and Max Healthcare Institute each have a clear plan to grow. Based on the 13 November 2026 close, TCPL Packaging trades at Rs 4,481.5, Paradeep Phosphates at Rs 140.41 and Max Healthcare Institute at Rs 947.1. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these packaging, fertiliser and hospital stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track packaging, fertiliser and hospital stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are packaging, fertiliser and hospital stocks?
Ans. Packaging, fertiliser and hospital stocks are listed companies that make folding cartons and packaging for consumer brands, make phosphate fertilisers for farmers, and run multi speciality hospitals. Their earnings depend on packaging orders, farm demand and patient volumes. This list looks at three of them, TCPL Packaging, Paradeep Phosphates and Max Healthcare Institute, using reported FY22 to FY26 financials and the 13 November 2026 closing prices.
Which packaging, fertiliser and hospital stocks are covered in this list?
Ans. This list covers TCPL Packaging, Paradeep Phosphates and Max Healthcare Institute. Based on the 13 November 2026 close, TCPL Packaging traded at Rs 4,481.5, Paradeep Phosphates at Rs 140.41 and Max Healthcare Institute at Rs 947.1. Their return on equity ranges from 13.4% to 14.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.0% to 29.1%.
Why do packaging, fertiliser and hospital stocks have a strong future roadmap in India?
Ans. Packaging, fertiliser and hospital stocks have a strong roadmap in India because rising demand for printed packaging, steady farm activity and rising need for quality hospital care keep widening the market for these companies. The main drivers are as follows. Packaging. Brands need quality retail packs. Fertilisers. Farmers need crop nutrients. Hospitals. Families seek quality specialist care. Together these factors give the companies on this list a visible path for growth over the coming years.
How has TCPL Packaging performed financially?
Ans. Revenue rose from Rs 1,089 crore in FY22 to Rs 1,836 crore in FY26, a compound annual growth rate of 14.0%. Net profit grew from Rs 46.9 crore in FY22 to Rs 97.8 crore in FY26, which works out to a compound annual growth rate of 20.2%. In the June 2026 quarter, revenue grew 15.9% year on year to Rs 495 crore, while net profit rose 79.3% to Rs 40.0 crore. The company has a return on equity of 13.6%, a debt to equity ratio of 0.88 and a market capitalisation of Rs 3,524 crore. The stock trades at a P/E of 30.5, above the industry P/E of 21.7. Looking ahead, the company is investing in new plants and printing technology to serve brand owners who want quality packaging at scale. Rising packaged consumption supports steady volume growth.
How has Paradeep Phosphates performed financially?
Ans. Revenue rose from Rs 7,898 crore in FY22 to Rs 21,973 crore in FY26, a compound annual growth rate of 29.1%. Net profit grew from Rs 398 crore in FY22 to Rs 996 crore in FY26, which works out to a compound annual growth rate of 25.8%. In the June 2026 quarter, revenue grew 35.4% year on year to Rs 6,146 crore, while net profit rose 23.9% to Rs 393 crore. The company has a return on equity of 14.7%, a debt to equity ratio of 1.02 and a market capitalisation of Rs 15,007 crore. The stock trades at a P/E of 14.0, below the industry P/E of 21.2. Looking ahead, the company has expanded capacity and is working to increase volumes of complex fertilisers across its network. Its coastal location supports imports of raw material, and expansion plans support future volumes.
How has Max Healthcare Institute performed financially?
Ans. Revenue rose from Rs 4,059 crore in FY22 to Rs 8,536 crore in FY26, a compound annual growth rate of 20.4%. Net profit grew from Rs 605 crore in FY22 to Rs 1,442 crore in FY26, which works out to a compound annual growth rate of 24.3%. In the June 2026 quarter, revenue grew 16.6% year on year to Rs 2,407 crore, while net profit rose 4.9% to Rs 323 crore. The company has a return on equity of 13.4%, a debt to equity ratio of 0.32 and a market capitalisation of Rs 80,717 crore. The stock trades at a P/E of 55.4, below the industry P/E of 59.6. Looking ahead, the roadmap rests on adding beds through brownfield expansion at existing campuses and through new hospitals in cities where the group already has referral strength. Higher bed occupancy and a richer case mix lift revenue per occupied bed, which is the number hospital analysts follow most closely.
What risks should investors check before buying packaging, fertiliser and hospital stocks?
Ans. Investors should check a few risks before buying packaging, fertiliser and hospital stocks. Raw material costs. Ingredient and packaging prices can move margins. Season and monsoon. Crop protection sales follow rain and pest cycles. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of packaging, fertiliser and hospital stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 13 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
Recent Articles

Bank Stocks at 52-Week High: Kotak Mahindra Bank, PNB and Union Bank Touch New Highs as Foreign Money Returns
16 November 2026

Superstar Investor Portfolio Tracking: How to Read Quarterly Shareholding Data Without Copying Blindly
16 November 2026

Breakout Stocks Today: Fresh Daily Breakouts on NSE, the Criteria Used and How to Confirm a Breakout
16 November 2026

52 Week High Stocks Today: Live NSE and BSE List, What Triggered Each Move and How to Read It
16 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Bank Stocks at 52-Week High: Kotak Mahindra Bank, PNB and Union Bank Touch New Highs as Foreign Money Returns
Superstar Investor Portfolio Tracking: How to Read Quarterly Shareholding Data Without Copying Blindly
Breakout Stocks Today: Fresh Daily Breakouts on NSE, the Criteria Used and How to Confirm a Breakout
52 Week High Stocks Today: Live NSE and BSE List, What Triggered Each Move and How to Read It
Stocks to Buy Today: Short-Term and Long-Term Research Ideas From SEBI-Registered Analysts

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





